Kaplan-Meier survival analysis demonstrated that cervical cancer patients with low E2F8 levels exhibited longer overall survival and disease-free survival than cervical cancer patients with high E2F8 levels (p=0.035 and 0.028, respectively Figure 1C and D). This evidence concerns the gene E2F8 and cervical carcinoma.